Genentech posted a 41 percent increase in its profits for the company's recently completed second quarter on Wednesday in part on the strength of its cancer drugs.

Genentech's Avastin drug, which treats lung, breast and colon cancer, saw sales for the April-June period of this year rise 33 percent to $564 million.


If you're an Avastin customer, has the drug helped with your specific cancer and have you been pleased with the results? I've never met anyone using this drug and have been curious to see what effects it does have on the cancer types it is marketed to fight against.


The main source for this article is TheCancerBlog